The 20 Best Pancreatic Cancer Doctors Near Me

Gary Schwartz is a Hematologist Oncology provider in Cleveland, Ohio. Dr. Schwartz has been practicing medicine for over 47 years and is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Fibrosarcoma, Hepato-Pancreato-Biliary Surgery, and Liver Embolization.

Shishir Maithel is a Surgical Oncologist in Chicago, Illinois. Dr. Maithel has been practicing medicine for over 26 years and is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Pancreatic Islet Cell Tumor, Pancreaticoduodenectomy, and Hepatectomy.

Amer H. Zureikat, MD, is vice chair of surgery for surgical oncology in the Department of Surgery at UPMC, chief of Surgical Oncology at UPMC Hillman Cancer Center, and UPMC Chair of Clinical Surgery. He is the division chief for gastrointestinal surgical oncology in the Department of Surgery at UPMC and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Zureikat specializes in cancers and diseases of the pancreas, stomach, liver and duodenum and is an expert in robotic pancreatic surgery. His clinical and academic interests include the multimodality treatment of pancreatic cancer, and comparative effectiveness of open and robotic approaches to gastrointestinal cancers in general and pancreatic cancer in particular.Dr. Zureikat is board-certified in general surgery. He received his medical degree from the Royal College of Surgeons in Dublin, Ireland, completed his general surgery residency at the University of Chicago Medical Center and his fellowship in surgical oncology at the University of Pittsburgh/UPMC. Dr. Zureikat is a member of the Society of University Surgeons (SUS), Society of Surgical Oncology (SSO), and the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition, he is a fellow of the American College of Surgeons (ACS). Dr. Zureikat is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

David Kooby is a Surgical Oncologist in Atlanta, Georgia. Dr. Kooby has been practicing medicine for over 32 years and is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Stomach Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Charles Yeo is an Oncologist and a General Surgeon in Philadelphia, Pennsylvania. Dr. Yeo is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Yeo is currently accepting new patients.

Dr. O'Shaughnessy is a Medical Oncologist that focuses on breast cancer prevention and treatment. She founded The School of Breast Oncology, a program providing a curriculum-based program focused exclusively on breast cancer clinical management. Dr. O'Shaughnessy attended medical school at Yale University School of Medicine in New Haven, CT. She then completed her Internal Medicine residency at Massachusetts General Hospital in Boston, MA and a Medical Oncology fellowship at National Cancer Institute in Bethesda, MD. She is co-chair of Breast Cancer Research, chair of Breast Cancer Prevention Research at Baylor Charles A. Sammons Cancer Center and a member of the Scientific Advisory Board for US Oncology Research Network. Dr. O'shaughnessy is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Inflammatory Breast Cancer, and Tissue Biopsy.

Theodore Hong is a Radiologist in Needham, Massachusetts. Dr. Hong is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Anal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Tissue Biopsy.

I enjoy traveling, dancing and food. Dr. Shroff is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy.

Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy.

Melissa Hogg, MD, a surgical oncologist at Endeavor Health, provides advanced, minimally invasive surgical care for patients with cancer and complex conditions. She specializes in robotic-assisted procedures and evidence-based treatment strategies that promote both longevity and quality of life. Dr. Hogg is also dedicated to surgical education and innovation, ensuring that advances in technology and training continue to enhance patient safety and outcomes. Dr. Hogg is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Gastrointestinal Fistula, Pancreaticoduodenectomy, and Pancreatectomy.

I am a cancer surgeon who specializes in treating patients with pre-cancerous and cancerous conditions of the pancreas, liver, bile ducts, stomach, and adrenal glands. I initially trained and practiced at Walter Reed Army Medical Center in Washington, D.C. During this time, I served one year on a forward surgical team in Iraq. Following this service, I practiced for 13 years as a surgical oncologist at Memorial Sloan Kettering Cancer Center in New York. In 2018, I joined the faculty at Duke University and now serve as the chief of surgical oncology for Duke Health. I enjoy getting to know my patients and delivering the highest quality of cancer care. I am dedicated not only to treating and curing your cancer, but also providing you with the highest quality of life. Operations for cancers within the abdomen are a serious undertaking, and I am committed to making sure that they are performed with the highest level of expertise. Dr. Allen is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, Pancreatectomy, and Hepatectomy.

David Mcdermott is an Internal Medicine specialist and an Oncologist in Boston, Massachusetts. Dr. Mcdermott is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.

Dr. Daniel Laheru is a cancer specialist in Baltimore, caring for patients with pancreatic cancer, colorectal cancer and neuroendocrine cancers. Dr. Laheru serves as co-director of the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care at Johns Hopkins Medicine. Dr. Laheru received his undergraduate degree in chemistry from The University of Utah. He earned his M.D. at Baylor College of Medicine. He completed his residency at The University of Utah Hospital and Clinics and performed a fellowship in medical oncology at The Johns Hopkins University School of Medicine and The Johns Hopkins Oncology Center. Dr. Laheru joined the Johns Hopkins faculty in 2001. Dr. Laheru's research interests include pancreatic cancer and chemotherapy resistance in pancreatic cancer. With Elizabeth Jaffee, M.D., he developed a vaccine that supercharges the immune system and causes immune cells, which tend to be tolerant of cancer, to seek out and kill pancreatic cancer cells throughout the body. He has given numerous invited talks on pancreatic cancer and other cancers both nationally and internationally. He has authored over 200 papers focused on pancreatic cancer. Dr. Laheru serves as associate editor of Annals of Pancreatic Cancer. He has been recognized by the American Society of Clinical Oncology with the Young Investigator Award, by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as an Isaac and Catharine Hecht Scholar and has been elected to the Miller-Coulson Academy of Clinical Excellence. He is a member of the American College of Physicians, the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Laheru is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Dr. Michael Pishvaian is the director of Gastrointestinal, Developmental Therapeutics and Clinical Research Programs for the Johns Hopkins Kimmel Cancer Center in the Greater Washington Area and an associate professor at the School of Medicine. Dr. Pishvaian is a fellowship-trained gastrointestinal oncologist specializing in pancreatic and refractory colorectal cancers. He is committed to precision medicine and provides his patients with the most appropriate and advanced level of care. He conducts all phases of clinical trials for all GI cancers and enrolls qualifying patients. Click here to learn more about oncology clinical trials the Greater Washington Area. Dr. Pishvaian is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Bradley Carthon is an Oncologist in Atlanta, Georgia. Dr. Carthon has been practicing medicine for over 21 years and is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Prostatectomy.

Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine.  He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy.

Matthew Yurgelun is an Oncologist in Milford, Massachusetts. Dr. Yurgelun is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Lynch Syndrome, Pancreatic Cancer, Familial Pancreatic Cancer, Colonoscopy, and Endoscopy.

Omer Kucuk is an Oncologist in Atlanta, Georgia. Dr. Kucuk has been practicing medicine for over 51 years and is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Prostatectomy.

Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Elite provider by MediFind in the treatment of Pancreatic Cancer. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy.

. Dr. Shipstone is rated as a Distinguished provider by MediFind in the treatment of Pancreatic Cancer. His top areas of expertise are Adult Immune Thrombocytopenia, Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, and Thrombocytopenia.